Effect of Pulmonary Rehabilitation on Pulmonary Diseases and Its Effect on Medication Usage: A Prospective Observational Study

Atiya Nasreen Tara; Surabi Harsha; Rahila Tarannum; Saniya Naaz; Sahithi Chirumalla; Noorien Tasmiya; Dayakar Koppu

doi:10.38022/ajhp.v6i3.151

Atiya Nasreen Tara Assistant Professor, Department of Pharmacy Practice, Smt. Sarojini Ramulamma College of Pharmacy, Seshadrinagar, Mahabubnagar – 509001, Telangana, India
atiyatara30@gmail.com
Surabi Harsha Pharm.D Students, Department of Pharmacy Practice, Smt. Sarojini Ramulamma College of Pharmacy, Seshadrinagar, Mahabubnagar – 509001, Telangana, India
Rahila Tarannum Pharm.D Students, Department of Pharmacy Practice, Smt. Sarojini Ramulamma College of Pharmacy, Seshadrinagar, Mahabubnagar – 509001, Telangana, India
Saniya Naaz Pharm.D Students, Department of Pharmacy Practice, Smt. Sarojini Ramulamma College of Pharmacy, Seshadrinagar, Mahabubnagar – 509001, Telangana, India
Chirumalla Sahithi Pharm.D Students, Department of Pharmacy Practice, Smt. Sarojini Ramulamma College of Pharmacy, Seshadrinagar, Mahabubnagar – 509001, Telangana, India
Tasmiya Noorien Pharm.D Students, Department of Pharmacy Practice, Smt. Sarojini Ramulamma College of Pharmacy, Seshadrinagar, Mahabubnagar – 509001, Telangana, India
Koppu Dayakar Pharm.D Students, Department of Pharmacy Practice, Smt. Sarojini Ramulamma College of Pharmacy, Seshadrinagar, Mahabubnagar – 509001, Telangana, India

DOI https://doi.org/10.38022/ajhp.v6i3.151

Abstract

Background: Pulmonary rehabilitation (PR) is a non-pharmacological, multidisciplinary intervention that helps people with chronic lung disease breathe and function better. This study examined the effect of PR on patients with pulmonary diseases and on their medication use, assessed with the Morisky Medication Adherence Scale.

Objectives:To evaluate the effect of pulmonary rehabilitation on pulmonary diseases and to assess the medication adherence among those patients.

Methods: A prospective observational study was conducted over 6 months in the Department of Pulmonary Medicine, SVS Medical College and Hospital, Mahabubnagar. Data were collected from 90 patients (98 cases were initially collected) using a data collection form, patient information leaflets (PIL) and the 8-item Morisky Medication Adherence Scale (MMAS-8). Twenty patients underwent PR (6-minute walk test, yoga asanas or breathing exercises) with pharmacist counselling. Adherence scores were recorded before and after rehabilitation.

Results: Of 90 patients, 46 (51.1%) were male and the 36–40-year group was the largest (35 patients, 38.9%). Bronchial asthma (33.3%) and bronchiectasis (31.1%) were the most frequent diagnoses, and 39 patients (43.3%) were smokers. Twenty patients (22.2%) underwent PR. The mean MMAS-8 score changed from 8.44 before to 5.64 after rehabilitation (mean difference 2.80; paired Student’s t-test, t = 12.08, df = 19, p < 0.0001).

Conclusion: Pulmonary rehabilitation was associated with a marked change in medication adherence scores in patients with chronic lung disease resulting in increase in quality of life and decrease in medication adherence and resistance. Larger, controlled studies are needed to evaluate it in detail.

Keywords: Pulmonary rehabilitation, medication adherence, MMAS-8, chronic obstructive pulmonary disease, asthma

Downloads

Download data is not yet available.

References

1. Leonshargel, Muthik AH, Souney PF, Swanson LN. Comprehensive Pharmacy Review. 8th ed. Wolters Kluwer; 2013. p. 852-860.
2. Harsh Mohan P. Textbook of Pathology. 6th ed. Jaypee Brothers; 2010. p. 477-482.
3. Wells BG, DiPiro JT. Textbook of Pharmacotherapy. 7th ed. McGraw Hill Medical; 2005. p. 537-538.
4. Ravishankar K, Kiranmayi GVN. Clinical Pharmacy and Pharmacotherapeutics. Pharma Med Press; 2013. p. 336-345.
5. Fabbri LM, et al. Global strategy for the diagnosis, management and prevention of COPD. EurRespir J. 2003;22:1-2.
6. Walker R, Whittlesea C. Clinical Pharmacy and Therapeutics. 5th ed. Elsevier; 2013. p. 431-442.
7. Tripathi KD. Essentials of Medical Pharmacology. 6th ed. Jaypee Brothers; 2010. p. 217-225.
8. Wouters EFM, et al. Systemic effects in COPD. EurRespir J. 2003;22(46):1.
9. Celli BR, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. EurRespir J. 2004;23:932-946.
10. Parthasarathi G, Nyfort-Hansen K, Nahata MC. A Textbook of Clinical Pharmacy Practice: Essential Concepts and Skills. 2nd ed. Universities Press; 2013. p. 71, 441-447.
11. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
12. Mitchell DM, et al. Introduction to chronic obstructive pulmonary disease. Thorax. 2001;56(2):1-2.
13. Bourbeau J, et al. Patient adherence in chronic obstructive pulmonary disease. Thorax. 2008;63:831-838.
14. Restrepo RD, et al. Medication adherence issues in patients treated for COPD. Int J COPD. 2008;3(3):371-384.
15. Doke JJ, et al. Medication adherence pattern in COPD. Chest. 1991;99:837-841.
16. Rand CS, et al. Patient adherence with COPD therapy. EurRespir Rev. 2005;14(96):97-101.
17. Hawwa, et al. Potential risk factors of medication non-adherence in patients with COPD. Eur J ClinPharmacol. 2012;68(10):1365-1373.
18. Veettil SK, et al. Study of drug utilization pattern for acute exacerbation of chronic obstructive pulmonary disease in patients attending a government hospital in Kerala, India. J Family Med Prim Care. 2014;3(3):250-254.
19. Sanduzzi A, et al. COPD adherence to therapy. Ther Clin Risk Manag [journal name as given: Biomed]. 2014;9(60):1-9.
20. George J, et al. Factors associated with medication non-adherence in patients with COPD. Chest. 2005;128:3198-3204.
21. Bishop EWMA, et al. Effects of written action plan adherence on COPD exacerbation recovery. Thorax. 2011;66:26-31.
22. Loferest L, et al. Correlates of adherence to respiratory drugs in COPD patients. Prim Care Respir J. 2010;19(2):148-154.
23. Make B, et al. Under treatment of COPD: a retrospective analysis of US managed care and Medicare patients. Int J COPD. 2012;1:1-9.
24. Aleemuddin NM, et al. A cross sectional study on prescribing patterns and patients suffering from respiratory disorders in a teaching hospital of south India. J Cont Med A Dent. 2014;2(1):1-17.
25. Jung E, et al. Medication adherence and persistence in the last year of life in COPD patients. Respir Med. 2009;103:525-534.
26. Miravitlles M, et al. Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med. 2007;101:1753-1760.
27. Barbeau J, et al. Practice pattern in the management of COPD in primary practice: the CAGE study. Can Respir J. 2008;15(1):13-19.
28. Ramanath KV, et al. A study on medication adherence and quality of life in asthma and COPD of rural population in a tertiary care hospital. Indo Global J Pharm Sci. 2011;1(4):315-327.